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Abstract 
Vestibular migraine is a disorder associated with symptoms of vertigo, imbalance or dizziness. The duration of 
attacks varies from seconds to days but usually lasting minutes to hours. The pathophysiology of Vestibular 
Migraine is not well understood, however, studies have shown a dysfunctional thalamo-cortical apparatus may 
play a role in the etiology. Diagnostic tests are usually normal in patients afflicted with vestibular migraine, 
however, they can be used to rule out other vestibular disorders. A detailed physical exam and history 
suggesting recurrent vestibular symptoms and a history of migraine may point to the diagnosis. Management of 
vestibular migraine has shown to be effective using a combination of lifestyle modifications, vestibular 
rehabilitation and medications.  
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1. Introduction  
Vestibular migraine is one of the most common vestibular disorders affecting up to 1% of the general population 
[1] and 11% of patients in specialized vestibular clinics [2]. Among patients with dizziness and disequilibrium 
from tertiary clinics, vestibular migraine is considered the most common neurotologic condition [1]. Familial 
occurrence of vestibular migraine with autosomal dominant inheritance has been documented in several families 
[3], however, women were often affected two to three times more than men [4]. Vestibular migraine is not only 
prevalent amongst adults, but is also identified amongst the pediatric population of children and adolescents [5].  
------------------------------------------------------------------------ 
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Vestibular migraine presents with vertigo and dizziness in the presence of migraine. It is still widely unknown 
and therefore under-diagnosed in patients [6]. Based on the diagnostic criteria for vestibular migraine, the 
frequency of diagnosis was 7% in a study group of 200 dizziness clinic patients and 9% in a group of 200 
migraine clinic patients [7]. More studies should be done to understand the complexity of vestibular migraine 
and its accurate diagnosis.  
2. Epidemiology 
Migraine and dizziness are two common disorders that affect the general population, with a lifetime prevalence 
of 13-16% for migraine [8] and 7% for dizziness [9]. With the rise of several clinical studies, researchers have 
recently in the last decades begun acknowledging an association between the two disorders [10], also otherwise 
known as vestibular migraine.  
The lifetime prevalence of vestibular migraine is estimated to be 0.98% [11], though people can suffer from it at 
any age throughout their lives [12, 13]. Vestibular migraine also tends to occur later in life, especially in patients 
who have already suffered earlier from migraine headaches and in patients who have previously been headache-
free for years [7,14]. In terms of gender distribution, females seem to present with vestibular migraines more 
frequently than males. According to multiple studies, for every 1 male who presents with vestibular migraine, 
1.5 to 5 females is reported to suffer from it [7, 14, 12]. 
3. Pathophysiology 
Russo and colleagues [15] described the thalamus as a pivotal neuroanatomical structure responsible for 
migraine. They explored the functional response of vestibular neural pathways using whole-brain blood oxygen 
level dependent (BOLD) fMRi during caloric vestibular stimulation [15]. The thalamus is a key structure in 
transmitting sensory input from the brainstem to the cortex and signal perception depends on modulating effects 
of this gate [15]. The thalamus exerts supreme importance in pain processing and cortical excitability control 
[16]. The role of the mediodorsal thalamus in vestibular migraine pathophysiology could perhaps signify a 
dysfunctional vestibulo-thalamocortical network, which overlaps with the migraine circuit [17]. Further, 
processing between the thalamus and the cortex integrates vestibular, visual, proprioceptive, and somatosensory 
afferent inputs [15]. 
The “Spreading Depression” theory may also be a key in understanding migraine attacks. Cortical spreading 
depression (CSD) is a short-lasting depolarization wave that moves across the cortex at a rate of 3-5 mm/min. A 
brief phase of excitation signals the reaction, following nerve cell depression and an efflux of excitatory amino 
acids from nerve cells [18]. Upon reaching the vestibular cortex or even the brainstem vestibular nuclei, the 
wave of CSD can result in causing vestibular symptoms. Further, current evidence indicates that CSD is a 
possible primary event in the trigeminovascular system (TGVS) activation in migraine with aura, and perhaps 
also, migraine without aura. Dysfunctional brainstem nuclei involved in the central control of pain may favor 
central trigeminal hyperexcitability. Additionally, the relationship between abnormal cortical activity and 
abnormal brainstem function remains unclear [19]. 
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4. IHS Criteria 
Vestibular migraine is a migraine disorder that presents with vertigo, dizziness, and balance disturbance, with 
the attack duration ranging from seconds to days [20]. Aura phenomena, especially visual and somatosensory 
symptoms common to migraines with aura, may be present before, during, or after the headache during an attack 
[20], but symptoms vary greatly between patients. The International Headache Society [21] has identified 
criteria for migraine with and without aura, however, it does not include vestibular migraine as a distinct entity. 
 
Figure 1: The International Classification of Headache Disorders, 3rd edition(beta-version)[21] 
5. Diagnostic Criteria 
Vestibular migraine patients typically present with a combination of migraine and vestibular symptoms [22]. 
Further investigation must assess whether there exists a strong association between these disorders, or if they 
simply manifest independently. According to the criteria of the International Headache Society, the vestibular 
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symptoms in patients with migraine are unrelated. As a result, many patients with both migraine and vestibular 
symptoms do not have a specific diagnosis to account for their vestibular symptoms [11]. Further study should 
be done to understand whether these patients have a recognized independent vestibular disorder such as 
Ménière’s disease, BPPV, or vestibular neuritis.  
Challenges to diagnosis of vestibular migraine include variation in the nature of patients’ dizziness, the clarity of 
distinct attacks, the length of these attacks, and the time lapsed between the appearance of migrainous and 
vestibular symptoms [23]. Because physical examinations and laboratory assessments do not yield any 
pathognomonic findings, vestibular migraines are often diagnosed through exclusion of alternative diagnoses. 
The lack of physical examination or laboratory irregularities that would otherwise point toward other diagnoses 
could suggest a diagnosis of vestibular migraine. Besides exclusion, the diagnostic criteria for vestibular 
migraine are widely centered around a patient’s history [23] 
It was not until Neuhauser and colleagues developed diagnostic criteria for what is now termed vestibular 
migraine, a disorder in which vestibular symptoms are judged as part of the migrainous disorder itself 
[11].  According to the American Academy of Neurology, nearly 1% of the general population meets these 
criteria, which is five to ten times higher than the prevalence of Ménière’s disease [24]. Neuhauser and his 
colleagues’ criteria for vestibular migraine have been re-assessed favorably in a recent long-term follow-up 
paper. A structured diagnostic interview using the criteria has been used in studies of the clinical features, 
epidemiology, genetics, pathophysiology, and treatment of vestibular migraine.  
The degree to which balance symptoms in the absence of headaches affect the functioning of a patient is a 
common diagnostic factor of vestibular migraine. If vestibular symptoms interfere with a person’s daily 
activities, the balance symptoms are considered moderate. If these symptoms more frequently restrict one from 
performing daily activities, they are deemed to be severe. Both moderate and severe symptoms are characteristic 
of patients with vestibular migraine. If vestibular symptoms neither interfere nor restrict one’s daily activities, 
differential diagnoses should be considered [25].  
The International Headache Society’s current diagnostic criteria for vestibular migraine includes -- A) A current 
or past history of migraine with aura or migraine without aura. B) At least five episodes fulfilling criteria C and 
D. C) Vestibular symptoms of moderate or severe intensity, lasting from 5 minutes to 72 hours. D) At least 50% 
of the episodes are associated with one or more of the following three migrainous features: 1. Headache with at 
least two of the following features: Unilateral location, pulsating quality, moderate or severe intensity, 
aggravation by routine physical activity; 2. Photophobia and phonophobia; 3. Visual aura. E) Not better 
accounted for by another ICHD-3 diagnosis or by another vestibular disorder [21].  
Further, in a study done by Murdin and colleagues, a lifetime prevalence estimates of dizziness ranged between 
17 and 30%, and for vertigo between 3 and 10% [26]. Studies in the past have established an association 
between migraine and vertigo [27, 28, 29]. Vertigo is two to three times more common in patients with migraine 
than in patients with tension-type headaches. Symptoms of migraine are shown to be enhanced amongst patients 
already suffering from vertigo. The lifetime prevalence of migraine (16%) and vertigo (7%) lead to an expected 
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comorbidity in 11% of the general population. According to a recent study identified by the German National 
Health Survey, individuals with migraine were more likely to have vertigo and vertigo with an accompanying 
headache [27,28, 29]. 
6. Clinical Presentation 
Symptoms of vestibular migraine are episodic in nature, but the duration of attacks is highly variable, ranging 
from seconds to days [11, 30]. Headache associated with migraine generally precedes the onset of vestibular 
migraine [14]. The clinical presentation of vestibular symptoms that often correlate with migraine includes-but 
is not limited to - dizziness; motion intolerance with respect to head, eyes, and/or body; spontaneous vertigo 
attacks (often accompanied by nausea and vomiting); diminished eye focus with photosensitivity; sound 
sensitivity and tinnitus; balance loss and ataxia; cervicalgia (neck pain) with associated muscle spasms in the 
upper cervical spine musculature; confusion with altered cognition; spatial disorientation; and anxiety/panic 
[31]. 
Vertigo associated with vestibular migraine includes positional, head motion-induced, and visually induced 
vertigo [25]. In temporal association with balance symptoms, hearing loss or ringing in the ears may be 
experienced. However, these symptoms may require additional thorough evaluation to consider the possibility of 
a nonmigrainous comorbid otologic disorder [25]. Other clinical signs include lightheadedness, a swimming 
sensation, heavy headedness, a rising sensation, a tingling sensation, a rocking sensation, and excessive motion-
sickness susceptibility [23].   
With half or more of the dizziness episodes, at least one of the following symptoms manifest. A headache 
initially occurs displaying two or more of these characteristics - one-sided location, pulsing, moderate to severe 
pain intensity, or escalated pain brought upon by routine physical activity. Second, elevated sensitivity to both 
normal room lighting and sounds is notable. The person reports the necessity to stay in a room with minimal 
light and sounds, avoiding sunlight and all noise. Third, visual aura is experienced, such as visual scotoma or 
visual hallucination [25]. 
Another common sign that clinicians can use to help in accurately diagnosing vestibular migraines is nystagmus, 
or involuntary eye movement. A recent study from 2010 identified eye movement findings in vestibular 
migraine patients while symptomatic during an attack; symptomatic subjects were reported to have difficulty in 
exhibiting smooth eye pursuit [32]. Interestingly, all patients exhibited positional nystagmus, which either 
happened spontaneously or were stimulated by headshaking [32]. Horizontal headshaking was identified to be 
the most common direction that triggered nystagmus. Other less common types of positional nystagmus 
recorded in the study included vertical nystagmus and torsional nystagmus [32]. Spontaneous positional 
nystagmus was also commonly reported and the eye movements during a vestibular migraine attack were of low 
velocity and sustained [32]. Furthermore, symptoms of migraine may occur simultaneously with symptoms of 
vestibulopathy [11]. Vestibular migraine symptoms are often identical to those of other sources of dizziness, 
including and most notably Ménière’s disease and Benign Paroxysmal Positional Vertigo (BPPV) [23]. 
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7. Physical Exam/Testing 
Vestibular migraine is often challenging to diagnose when the patient is asymptomatic, as many symptoms 
overlap with other conditions. Discerning peripheral vs. central causes of vertigo with objective testing is crucial 
for accurate diagnoses. The Dix-Hallpike test and the head thrust may be performed for vestibular assessment. If 
these tests remain negative, central causes of the vertigo, such as, stroke, tumor, Multiple Sclerosis, or Migraine, 
must be thoroughly investigated. However, if the results of these exams are positive, BPPV should be 
considered and managed accordingly. The presence of nystagmus on physical exam can be a valuable tool for 
diagnosis. Patients on an asymptomatic day were reported to have normal eye movements and extraocular 
motion [32]. Studies have also found that ten to twenty percent of vestibular migraine patients tend to have 
unilateral hypo-excitability due to caloric stimulation. Additionally, patients usually have imbalance and show 
central vestibular findings during the acute phase of vestibular migraine [13]. 
It is important to note head shaking and positional changes that provoke nystagmus during vestibular migraine 
attacks, imply there may be multiple anatomic sites involved in vestibular migraine [32]. In fact, PET studies 
from various research studies indicate many sites in the brainstem are persistently activated during migraine 
attacks; these include the periaqueductal gray, dorsal raphe nucleus, and locus coeruleus. Blood oxygen level-
dependent fMRI studies also detected other interconnected structures of the brain affected during a migraine 
attack; these include the substantia nigra, red nucleus, and hypothalamus [32]. 
8. Differential Diagnoses 
Vestibular migraine often shares similar symptoms with various conditions, specifically those related to balance 
disorders. Vestibular migraine may present with purely positional vertigo, thus mimicking (BPPV). Latency of 
onset and rotational nystagmus are two key characteristics of a positive Dix-Hallpike test that is used to 
diagnose BPPV [33]. Positional nystagmus in vestibular migraine is similarly persistent; however for BPPV the 
symptomatic episodes tend to be shorter with vestibular migraine (minutes to days rather than weeks) and more 
frequent (several times per year with vestibular migraine rather than once every few years with BPPV) [33]. 
Over half of patients with Meniere’s Disease have a history of migraine, but migrainous headaches, 
photophobia, or aura are not typical of Meniere’s Disease [34]. Additionally, some literature suggests an 
association between Meniere’s Disease and Migraine Associated Dizziness (MAD). MAD exhibits multiple 
symptoms including motion intolerance, motion-provoked vertigo accompanied by lightheadedness, 
spontaneous intervals of vertigo lasting from seconds to days, tinnitus, as well as unilateral and bilateral 
perceived fluctuant hearing [13]. 
9. Treatment 
Treatment of vestibular migraine is most effective when offered early in the course of the illness. Avoiding 
triggers and reducing stress and anxiety is an important part of overall management [35]. A patient diary should 
be kept including severity, duration, and frequency of vestibular migraine attacks. 
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Triptans are 5HT-1B/1D receptor agonists developed to treat migraine headaches [36]. According to a 
retrospective study conducted in San Diego, the ability of triptans to relieve symptoms of migraine-associated 
vertigo, is directly correlated to its ability to alleviate headache [37]. Migraine therapy could be beneficial to 
patients with migraine-associated vestibular disorders. Sumatriptan is an effective medication in improving 
headache and vertigo [37]. Almotriptan (ALM) was suggested to be both effective and safe in reducing vertigo 
and headache, according to a small clinical study [39]. In this study, 12.5 mg of ALM was administered to 26 
subjects with vestibular migraine, to which 83% of the patients benefitted. 55% of patients reported complete 
disappearance of vertigo, 28% reported over 50% reduction, and 16% reported below 50% reduction. Pain was 
significantly reduced within the first month of treatment, and confirmed in the next two months. A limitation of 
this study, as acknowledged, was the small population size on which the results were based. The efficacy of 
almotriptan should be further examined in large scale, randomized, controlled clinical trials. 
Non-steroidal anti-inflammatory drugs, or NSAIDs are typically less expensive than triptans, and in some 
studies have shown to perform nearly as well in managing symptoms [40]. Available evidence suggests that 
ibuprofen in 200 and 400 mg doses are effective in reducing headache intensity and rendering patients pain free 
at 2 hours [43].  
Migraine prophylactic treatment has been shown to be widely effective in treating migraine-related vertigo [41]. 
In a study involving patients undergoing this treatment, a post-treatment analysis shows 69.3% reporting 
satisfactory control of symptoms, and 81.8% reporting at least a 50% reduction in the frequency of vertiginous 
episodes. Beta-blockers, such as propranolol and metoprolol are recommended for non-asthmatic patients with 
hypertension [41]. They, along with other prophylactic medications targeting headache treatment, were shown 
to be effective in treating vertigo and dizziness [37].  
Antiepileptics have been used for migraine prophylaxis in both adults and children. Examples of such drugs 
include, topiramate, valproic acid, leviteracetam, zonisamide and gabapentin. Topiramate is considered one of 
the first-line options for treatment of migraine in adults.  
10. Recommendations 
Additionally, alongside medication and vestibular rehabilitation, certain lifestyle modifications can benefit 
patients [36]. These include limiting the risk factors associated with migraine such as those relating to diet, 
sleep, stress and anxiety. Patients should strive to adopt a balanced diet, develop a regular sleep pattern, and 
acquire daily exercise habits. Stress reduction through relaxation methods, biofeedback, and cognitive-
behavioral therapy are highly recommended [38]. Such lifestyle changes are crucial in the prevention, 
management, and effective symptom reduction of vestibular migraine [42]. 
11. Conclusion 
In our practice at the University of Southern California, we notice several trends in patients with Migraines and 
vestibular symptoms.  A good history categorizing the symptoms and signs associated with the syndrome will 
help guide diagnosis and treatment. 
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When a history and physical exam cannot determine if vestibular symptoms versus Vestibular Migraine, and 
there are no contraindications to therapy, we treat using standard FDA approved medications 
We noticed that if a patient's migraine headache and its associated symptoms including photophobia, 
phonophobia, nausea and vomiting respond to treatment, migraine-induced vestibular symptoms should have 
some degree of response. 
Patients may also present with Migraine and Benign Paroxysmal Positional Vertigo or Ménière's disease. 
Primary vestibular signs and symptoms will persist after successful treatment of migraine. After good control of 
migraines has been achieved, withdrawal of medication may induce a return of both migraine symptoms and 
vestibular symptoms. 
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